Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Cash from Investing Activities: 2023-2024

Historic Cash from Investing Activities for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to -$300.8 million.

  • CG Oncology's Cash from Investing Activities fell 52.99% to $15.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$159.4 million, marking a year-over-year increase of 46.17%. This contributed to the annual value of -$300.8 million for FY2024, which is 148.17% down from last year.
  • As of FY2024, CG Oncology's Cash from Investing Activities stood at -$300.8 million, which was down 148.17% from -$121.2 million recorded in FY2023.
  • Over the past 5 years, CG Oncology's Cash from Investing Activities peaked at -$121.2 million during FY2023, and registered a low of -$300.8 million during FY2024.
  • In the last 2 years, CG Oncology's Cash from Investing Activities had a median value of -$211.0 million in 2023 and averaged -$211.0 million.
  • Data for CG Oncology's Cash from Investing Activities shows a maximum YoY plummeted of 148.17% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows CG Oncology's Cash from Investing Activities stood at -$121.2 million in 2023, then crashed by 148.17% to -$300.8 million in 2024.